---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-038620"
form_type: "8-K"
ticker: "OTLC"
cik: "0000908259"
company_name: "Oncotelic Therapeutics, Inc."
filed_at: "2023-10-30T23:59:59+00:00"
generated_at: "2026-06-09T06:29:20.608281+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Oncotelic closes 3rd tranche of unit financing, raising $1.05M via convertible notes and warrants

## Summary
- 42 units issued at $25,000 each for aggregate $1.05M; each unit includes a convertible note and 250,000 warrants.
- Notes convertible at $0.10/share; warrants exercisable at $0.12/share; placement agent fees of $157,500 paid.
- Debt of $1.05M from 27 accredited investors converted into the units under the subscription agreements.
- Third tranche of a financing previously reported in July 2023; total units subject to best-efforts placement agent agreement.

## SEC filing metadata
- accession: 0001493152-23-038620
- form_type: 8-K
- ticker: OTLC
- cik: 0000908259
- company_name: Oncotelic Therapeutics, Inc.
- filed_at: 2023-10-30T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/908259/000149315223038620/0001493152-23-038620-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/908259/000149315223038620/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-038620
- JSON: https://secwatch.observer/filing/0001493152-23-038620.json
- Plain text: https://secwatch.observer/filing/0001493152-23-038620.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.